Signaling pathways such as mitogen-activated protein kinase (MAPK) and nuclear factor kappaB (NF-κB) were also reported to have a significant impact on the resistance or sensitivity of cancer cells to TRAIL [95]. This evidence concerns the gene TNFSF10 and cancer.